Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-24-001677
Filing Date
2024-03-18
Accepted
2024-03-18 16:15:32
Documents
65
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q zeoscientifixinc_10q.htm   iXBRL 10-Q 447787
2 EXHIBIT 31.1 zeoscientifixinc_ex31-1.htm EX-31.1 16021
3 EXHIBIT 31.2 zeoscientifixinc_ex31-2.htm EX-31.2 16284
4 EXHIBIT 32.1 zeoscientifixinc_ex32-1.htm EX-32.1 5403
5 EXHIBIT 32.2 zeoscientifixinc_ex32-2.htm EX-32.2 5526
  Complete submission text file 0001829126-24-001677.txt   3152532

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE zeox-20240131.xsd EX-101.SCH 34198
7 XBRL CALCULATION FILE zeox-20240131_cal.xml EX-101.CAL 45720
8 XBRL DEFINITION FILE zeox-20240131_def.xml EX-101.DEF 107864
9 XBRL LABEL FILE zeox-20240131_lab.xml EX-101.LAB 233846
10 XBRL PRESENTATION FILE zeox-20240131_pre.xml EX-101.PRE 193601
68 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifixinc_10q_htm.xml XML 322525
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 24759219
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)